Contact
Please use this form to send email to PR contact of this press release:
eTheRNA Immunotherapies Selects Precision NanoSystems’ NxGen™ Technology for GMP Manufacturing
TO:
Jane Alleva
Precision Nanosystems
+1 778-877-5473